Silence Therapeutics Share Discussion Threads

[1gw] 04/12/2019 19:48

Short positions appear to have collapsed even further in November, going by the Euroclear shares on loan data (not a 1-1 correlation, but I think usually regarded as a reasonable indicator). From 2.4m average in September, to 0.3m average in October and down to just 49k average in November.

Hardly surprising perhaps given the price move, but interesting that shorts appear not to have been going back on to any material extent in November, notwithstanding kreature's declaration, despite the rapid rise in market cap (and the shareprophets article). The table below shows average shares on loan for each month this year, in millions, from the Euroclear data:

Nov 0.05
Oct 0.3
Sep 2.4
Aug 2.6
Jul 2.8
Jun 2.1
May 2.5
Apr 2.8
Mar 2.8
Feb 2.9
Jan 2.9

[jammydodger1] 04/12/2019 19:02

Tonight you people need to research ALGWBIG PLANS 100,000,000 million. Credit facility about to be approved and signed by a leading UK asset managerMcap of this company is only 5m nowWill be multiples And way past 20pDnt be left out in the cold

[napoleon 14th] 04/12/2019 18:10

wantage - who is your broker?

[hotmark] 04/12/2019 16:32

Gutted I sold out at c.£3 - Just bought back in

[volsung] 04/12/2019 16:11

Mental this share is

[wantage] 04/12/2019 15:32

Sorry, wrong ticker OBD, Oxford Biodynamics.They've got results next Tuesday.Will continue to report his recommendations.

[luckymouse] 04/12/2019 14:26

better post a picture of your broker then :D

[wantage] 04/12/2019 12:13

Will your chart tell us when we're going to float on Nasdaq? My broker put me in at 80p.He knows the company,and reckons £15 a suitable aiming mark.He also put me into Shield at the right price.FWIW, we are also building a position in OXB,a biotech
specialising in epigenetics.No reason this should not follow in their footsteps.

[horneblower] 04/12/2019 10:15

The chart continues to point to £8.
I'll review it when it gets there.

[pitball] 04/12/2019 09:24

I'm in profit. That's a first for many many years.

[pwilk47490] 04/12/2019 09:24

"Where's the guy who was advocating shorting this stock?". Topped himself?!?!?

Relentless AT's. No holding RNS's for ages, so still buying..... Surely something is about to happen here?

[secret investor] 04/12/2019 09:21

Where's the guy who was advocating shorting this stock?

[volsung] 04/12/2019 09:13

And still she rises...

[1gw] 03/12/2019 13:49

I've sold some today, crystallising the 10-bagger on the end-2018 value. With the 3 lots of profit-taking I've now sold in total around 25% of my end-2018 holding.

[1gw] 02/12/2019 21:27

Arwr announced a capital raise, taking advantage of the price spike. Ali had been speculating on twitter this was likely. Today's price fall on arwr may have been due at least in part to increasing speculation about a raise, but where will the money go? Back into arwr now it's fallen back, or elsewhere in the sector?

[1gw] 02/12/2019 20:24

ARWR down quite a bit (so far) today, DRNA and SLN up. Could we have a bit of switching?

[ny boy] 02/12/2019 17:38

Nice rise for the long term holders, hopefully (STX) to mirror this share price chart action off a 195p base at present.

[1gw] 02/12/2019 12:48

The trend is still our friend it would appear, at least for the longs. That's good volume this morning.

[pwilk47490] 02/12/2019 11:42

Shows delayed buys on LSE, but 2 x massive buys all the same! (I.e One not cancelling out the other due to mistake or anything!)


More Holdings declarations to come?

[volsung] 02/12/2019 11:42

Can't remember when I first bought in UKEaagle. Was quite a while ago though. Congrats on holding on for that profit. I am not selling any time soon so obv think there's a lot more to come.

[ukeagle2aus] 02/12/2019 11:32

Duplicate 70k trades at 575p? Maybe someone's order getting filled?

[ukeagle2aus] 02/12/2019 10:12

Nice one pitball, yeh mine were in the bottom drawer a long time ago, resurfacing and we'll and truely dusted down now. Another 5p and you're on way mate ?

[horneblower] 02/12/2019 10:09

My chart target is £8.